Long-term control of haemorrhagic brain metastases from atrial myxoma after radiotherapy

被引:0
|
作者
Khong, Jeremy [1 ,2 ]
Abou-Hamden, Amal [3 ]
Koszyca, Barbara [4 ]
Roos, Daniel [1 ,2 ]
Govindaraj, Ramkumar [1 ,2 ]
机构
[1] Royal Adelaide Hosp, Dept Radiat Oncol, Adelaide, SA, Australia
[2] Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA, Australia
[3] Royal Adelaide Hosp, Dept Neurosurg, Adelaide, SA, Australia
[4] Royal Adelaide Hosp, SA Pathol, Adelaide, SA, Australia
关键词
Cardiac; myxoma; metastasis; brain; radiotherapy; CARDIAC MYXOMA; CEREBRAL METASTASES; MANIFESTATIONS; COMPLICATIONS; EXPERIENCE; ANEURYSMS; SERIES;
D O I
10.1080/02688697.2024.2395373
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundCardiac myxoma is a rare, benign tumour that commonly originates in the left atrium and may lead to embolic events. Parenchymal brain metastases represent a rare neurological manifestation. While surgical intervention is commonly used, there is limited information on long-term outcomes after radiotherapy treatment. This report describes a case of successful treatment of haemorrhagic brain metastases with radiotherapy and offers a literature review of long-term results after radiotherapy treatment.Case reportA 49-year-old woman presented with multiple haemorrhagic brain lesions and a cardiac mass. Surgical removal of the cardiac mass and the symptomatic brain lesion confirmed metastatic cardiac myxoma. Post-surgery, she experienced fatigued and neurocognitive impairment and was closely monitored. However, the metastases progressed. She subsequently received whole-brain radiotherapy, resulting in complete response. Seven years later, she remains in remission, although with enduring neurocognitive impairment.ConclusionsWhole-brain radiotherapy can provide long-term control of haemorrhagic brain metastases arising from cardiac myxoma. Radiotherapy dose and treatment volume need careful consideration to reduce toxicity.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Long-term Course after Radiotherapy for cerebral Vascular Changes due to Atrial Myxoma - A Case Report
    Ginestet, A.
    Puttinger, G.
    Gindlhuber, K.
    Wagner, M.
    Gizewski, E.
    Poewe, W.
    Thome, C.
    Von Oertzen, T. J.
    Lukas, P.
    Ganswindt, U.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S46 - S47
  • [2] LONG-TERM SURVIVAL AFTER BRAIN METASTASES FROM TRACHEAL CARCINOMA
    ICHINOSE, Y
    HARA, N
    MOTOHIRO, A
    ASO, H
    KUDA, T
    HATA, K
    OHTA, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1990, 20 (01) : 107 - 109
  • [3] LONG-TERM FOLLOW-UP OF ATRIAL MYXOMA
    CROXSON, RS
    CLELAND, WP
    JEWITT, D
    BENTALL, HH
    KRISTINSSON, A
    GOODWIN, JF
    BRITISH HEART JOURNAL, 1972, 34 (10): : 1018 - +
  • [4] Important Factors for Local Control After Radiotherapy of Bone Metastases in Cases of Long-Term Survivors
    Makita, K.
    Hamamoto, Y.
    Kanzaki, H.
    Nagasaki, K.
    Ishikawa, H.
    Nishijima, N.
    Tsuruoka, S.
    Uwatsu, K.
    Kido, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E488 - E488
  • [5] Long-term neurocognitive function after whole-brain radiotherapy in patients with melanoma brain metastases in the era of immunotherapy
    Martin Salzmann
    Klaus Hess
    Kristin Lang
    Alexander H. Enk
    Berit Jordan
    Jessica C. Hassel
    Strahlentherapie und Onkologie, 2022, 198 : 884 - 891
  • [6] Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters
    Schmidberger, Heinz
    Rapp, Matthias
    Ebersberger, Anne
    Hey-Koch, Silla
    Loquai, Carmen
    Grabbe, Stephan
    Mayer, Arnulf
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (12) : 1144 - 1151
  • [7] Long-term neurocognitive function after whole-brain radiotherapy in patients with melanoma brain metastases in the era of immunotherapy
    Salzmann, M.
    Hess, K.
    Lang, K.
    Enk, A.
    Jordan, B.
    Hassel, J. C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2022, 20 : 16 - 16
  • [8] Long-term neurocognitive function after whole-brain radiotherapy in patients with melanoma brain metastases in the era of immunotherapy
    Salzmann, Martin
    Hess, Klaus
    Lang, Kristin
    Enk, Alexander H.
    Jordan, Berit
    Hassel, Jessica C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (10) : 884 - 891
  • [9] Long-term results of stereotactic radiotherapy in patients with ≥10 brain metastases at diagnosis
    Kinj, Remy
    Hottinger, Andreas
    Boehlen, Till
    Ozsahin, Mahmut
    Vallet, Veronique
    Dunet, Vincent
    Tuleasca, Constantin Tuleasca
    Bourhis, Jean
    Schiappacasse, Luis
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S754 - S755
  • [10] EXTRANEURAL METASTASES FROM MEDULLOBLASTOMA - LONG-TERM SURVIVAL AFTER SEQUENTIALLY SCHEDULED CHEMOTHERAPY AND RADIOTHERAPY
    MAHONEY, DH
    STEUBER, CP
    SANDBACH, JF
    FERNBACH, DJ
    MEDICAL AND PEDIATRIC ONCOLOGY, 1986, 14 (06): : 329 - 331